Appetite and obesity: a gastroenterologist's perspective.
This review focuses on the gastrointestinal tract's control of appetite and interventions directed to the gut that are effective in the treatment of obesity. It examines the evidence linking gut hormones to the control of both appetite and upper gastrointestinal motility, the evidence that stomach function is altered and contributes to satiation in obesity and outlines the principles of therapy for obesity which are directed at the gastrointestinal tract. These therapies impair fat absorption or alter stomach functions through pharmacological, device, endoscopic, or surgical approaches. Gastroenterologists need to understand the role of factors controlling appetite in order to effectively manage the increasing number of obese patients and the ways the gut function may be altered as a result of the treatments and their complications.
Camilleri
M
M
Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER) Group, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. camilleri.michael@mayo.edu
Grudell
A B M
AB
D001066:Appetite; D001069:Appetite Regulation; D004435:Eating; D005762:Gastroenterology; D005768:Gastrointestinal Hormones / Q000378:metabolism; D005769:Gastrointestinal Motility / Q000502:physiology; D041981:Gastrointestinal Tract / Q000502:physiology; D006801:Humans; D009765:Obesity / Q000503:physiopathology* / Q000628:therapy; D012527:Satiation
D005768:Gastrointestinal Hormones